Additionally, adrenomedullin could reduce FDX1 transcription and suppress cuproptosis in renal cell carcinoma (RCC) through promoting p38/MAPK signaling pathway-mediated phosphorylation and nuclear translocation of Forkhead box O3 (FOXO3) [72]. The gene discussed is FDX1; the disease is renal cell carcinoma.